Etavopivat
Product Specifications
UNSPSC Description
Etavopivat is a potent, selective, and orally active erythrocyte pyruvate kinase (PKR) activator. Etavopivat has potent antisickling effects that can be used in studies of sickle cell disease and other haemoglobinopathies[1][2].
Target Antigen
Pyruvate Kinase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/etavopivat.html
Smiles
O=S(N1CC2=C(CN(C2)C([C@@H](C3=CC=CC=C3)CO)=O)C1)(C4=CN=C(OCCO5)C5=C4)=O
Molecular Weight
457.50
References & Citations
[1]Shrestha A, et al. FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice. Blood Adv. 2021 May 11;5(9):2385-2390.|[2]Schroeder P, et al. Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease. J Pharmacol Exp Ther. 2022 Mar;380(3):210-219.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-139573/Etavopivat-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-139573/Etavopivat-SDS-MedChemExpress.pdf
CAS Number
2245053-57-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6242257-01 0.1 mL
Integrin, beta1 (CD29, Very Late Antigen, VLAb1, Platelet gplla) (APC)
Ask
View Details MBS6242257-02 5x 0.1 mL
Integrin, beta1 (CD29, Very Late Antigen, VLAb1, Platelet gplla) (APC)
Ask
View Details